Rank | Gene Set | Z-score |
---|---|---|
1 | Golgi transport vesicle coating (GO:0048200) | 9.27648657 |
2 | COPI coating of Golgi vesicle (GO:0048205) | 9.27648657 |
3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.95551515 |
4 | folic acid-containing compound biosynthetic process (GO:0009396) | 5.58728907 |
5 | COPII vesicle coating (GO:0048208) | 5.34881472 |
6 | protein retention in ER lumen (GO:0006621) | 5.15358358 |
7 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 5.10784224 |
8 | ribosomal large subunit biogenesis (GO:0042273) | 4.75212310 |
9 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.54987321 |
10 | positive regulation of nuclease activity (GO:0032075) | 4.49840289 |
11 | mitotic chromosome condensation (GO:0007076) | 4.24896561 |
12 | regulation of nuclease activity (GO:0032069) | 4.20203319 |
13 | establishment of integrated proviral latency (GO:0075713) | 4.18917654 |
14 | IMP biosynthetic process (GO:0006188) | 4.18348299 |
15 | CENP-A containing nucleosome assembly (GO:0034080) | 4.18259810 |
16 | formation of translation preinitiation complex (GO:0001731) | 4.16520946 |
17 | ribosome assembly (GO:0042255) | 4.15966947 |
18 | mitotic metaphase plate congression (GO:0007080) | 4.15641668 |
19 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.13985780 |
20 | mitotic sister chromatid segregation (GO:0000070) | 4.11583891 |
21 | chromatin remodeling at centromere (GO:0031055) | 4.09190064 |
22 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.07383045 |
23 | vesicle coating (GO:0006901) | 4.06856648 |
24 | sister chromatid segregation (GO:0000819) | 4.05703612 |
25 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.99818996 |
26 | DNA strand elongation (GO:0022616) | 3.97810431 |
27 | cellular response to unfolded protein (GO:0034620) | 3.95417161 |
28 | ribosomal small subunit assembly (GO:0000028) | 3.94000542 |
29 | protein maturation by protein folding (GO:0022417) | 3.81466423 |
30 | translational termination (GO:0006415) | 3.78522044 |
31 | metaphase plate congression (GO:0051310) | 3.78410301 |
32 | cellular response to topologically incorrect protein (GO:0035967) | 3.77723834 |
33 | tetrahydrofolate metabolic process (GO:0046653) | 3.76495759 |
34 | DNA replication checkpoint (GO:0000076) | 3.75703431 |
35 | signal peptide processing (GO:0006465) | 3.73512405 |
36 | sequestering of metal ion (GO:0051238) | 3.73039971 |
37 | viral transcription (GO:0019083) | 3.72527015 |
38 | ER-nucleus signaling pathway (GO:0006984) | 3.72463681 |
39 | ribosomal small subunit biogenesis (GO:0042274) | 3.71831410 |
40 | protein localization to chromosome, centromeric region (GO:0071459) | 3.70691990 |
41 | proteasome assembly (GO:0043248) | 3.69636324 |
42 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.66539935 |
43 | DNA topological change (GO:0006265) | 3.62581168 |
44 | telomere maintenance via recombination (GO:0000722) | 3.60122970 |
45 | mitotic recombination (GO:0006312) | 3.59366220 |
46 | nuclear pore organization (GO:0006999) | 3.57005609 |
47 | IMP metabolic process (GO:0046040) | 3.54817367 |
48 | nuclear pore complex assembly (GO:0051292) | 3.54221707 |
49 | exocrine pancreas development (GO:0031017) | 3.53401884 |
50 | kinetochore organization (GO:0051383) | 3.51956853 |
51 | nucleobase biosynthetic process (GO:0046112) | 3.48389106 |
52 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.47308395 |
53 | DNA replication-independent nucleosome organization (GO:0034724) | 3.47129547 |
54 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.47129547 |
55 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.44136594 |
56 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.42519226 |
57 | regulation of centriole replication (GO:0046599) | 3.41768020 |
58 | histone exchange (GO:0043486) | 3.39166170 |
59 | establishment of chromosome localization (GO:0051303) | 3.34325697 |
60 | regulation of mitotic spindle organization (GO:0060236) | 3.32811310 |
61 | ribosome biogenesis (GO:0042254) | 3.32546995 |
62 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.26946893 |
63 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.26891569 |
64 | translational elongation (GO:0006414) | 3.26767167 |
65 | peptidyl-asparagine modification (GO:0018196) | 3.24946095 |
66 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.24552600 |
67 | mitotic nuclear envelope disassembly (GO:0007077) | 3.24332400 |
68 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.23711979 |
69 | * translation (GO:0006412) | 3.23432847 |
70 | non-recombinational repair (GO:0000726) | 3.22652229 |
71 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.22652229 |
72 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.21655405 |
73 | DNA replication initiation (GO:0006270) | 3.21616811 |
74 | regulation of translational fidelity (GO:0006450) | 3.20236886 |
75 | response to endoplasmic reticulum stress (GO:0034976) | 3.19777219 |
76 | spindle checkpoint (GO:0031577) | 3.18335635 |
77 | * SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.16405594 |
78 | mitotic spindle checkpoint (GO:0071174) | 3.16216748 |
79 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 3.13679443 |
80 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 3.13679443 |
81 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 3.13679443 |
82 | negative regulation of sister chromatid segregation (GO:0033046) | 3.13679443 |
83 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 3.13679443 |
84 | negative regulation of chromosome segregation (GO:0051985) | 3.11991387 |
85 | mitotic sister chromatid cohesion (GO:0007064) | 3.11815856 |
86 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.11370786 |
87 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.10340680 |
88 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.09983142 |
89 | regulation of spindle organization (GO:0090224) | 3.08523673 |
90 | glucocorticoid receptor signaling pathway (GO:0042921) | 3.07812055 |
91 | * protein targeting to ER (GO:0045047) | 3.07466038 |
92 | response to unfolded protein (GO:0006986) | 3.07462775 |
93 | regulation of chromosome segregation (GO:0051983) | 3.07108489 |
94 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 3.06714656 |
95 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 3.06714656 |
96 | rRNA processing (GO:0006364) | 3.05846091 |
97 | * cotranslational protein targeting to membrane (GO:0006613) | 3.05414879 |
98 | purine nucleobase biosynthetic process (GO:0009113) | 3.04937124 |
99 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 3.04238622 |
100 | UMP metabolic process (GO:0046049) | 3.04238622 |
101 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 3.04238622 |
102 | UMP biosynthetic process (GO:0006222) | 3.04238622 |
103 | telomere maintenance via telomere lengthening (GO:0010833) | 3.03967186 |
104 | membrane disassembly (GO:0030397) | 3.03201655 |
105 | nuclear envelope disassembly (GO:0051081) | 3.03201655 |
106 | DNA ligation (GO:0006266) | 3.03137025 |
107 | mitotic spindle assembly checkpoint (GO:0007094) | 3.02191851 |
108 | regulation of sister chromatid segregation (GO:0033045) | 3.01641813 |
109 | regulation of mitotic sister chromatid separation (GO:0010965) | 3.01641813 |
110 | regulation of mitotic sister chromatid segregation (GO:0033047) | 3.01641813 |
111 | spindle assembly checkpoint (GO:0071173) | 2.98740183 |
112 | negative regulation of ligase activity (GO:0051352) | 2.97559550 |
113 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.97559550 |
114 | regulation of DNA endoreduplication (GO:0032875) | 2.96237437 |
115 | response to topologically incorrect protein (GO:0035966) | 2.96109237 |
116 | viral life cycle (GO:0019058) | 2.95461430 |
117 | * establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.93941728 |
118 | protein N-linked glycosylation (GO:0006487) | 2.93366371 |
119 | ATP-dependent chromatin remodeling (GO:0043044) | 2.92473817 |
120 | 4-hydroxyproline metabolic process (GO:0019471) | 2.92278083 |
121 | cellular protein complex disassembly (GO:0043624) | 2.92095079 |
122 | establishment of viral latency (GO:0019043) | 2.91981191 |
123 | ER overload response (GO:0006983) | 2.88431196 |
124 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.87939249 |
125 | * protein localization to endoplasmic reticulum (GO:0070972) | 2.86135182 |
126 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.85901851 |
127 | DNA unwinding involved in DNA replication (GO:0006268) | 2.85333901 |
128 | one-carbon metabolic process (GO:0006730) | 2.83096416 |
129 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.82861876 |
130 | folic acid-containing compound metabolic process (GO:0006760) | 2.74820760 |
131 | type B pancreatic cell development (GO:0003323) | 2.72819585 |
132 | endocrine pancreas development (GO:0031018) | 2.71159007 |
133 | regulation of translational termination (GO:0006449) | 2.69076001 |
134 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.61984407 |
135 | protein autoprocessing (GO:0016540) | 2.58321383 |
136 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.56287643 |
137 | pore complex assembly (GO:0046931) | 2.54569241 |
138 | tRNA aminoacylation for protein translation (GO:0006418) | 2.50071863 |
139 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.49307947 |
140 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 2.47472683 |
141 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 2.46037957 |
142 | corticosteroid receptor signaling pathway (GO:0031958) | 2.45730871 |
143 | cellular response to glucose starvation (GO:0042149) | 2.44421547 |
144 | protein localization to kinetochore (GO:0034501) | 2.43136524 |
145 | tRNA aminoacylation (GO:0043039) | 2.43055884 |
146 | amino acid activation (GO:0043038) | 2.43055884 |
147 | DNA duplex unwinding (GO:0032508) | 2.42815309 |
148 | negative regulation of RNA splicing (GO:0033119) | 2.41442437 |
149 | DNA geometric change (GO:0032392) | 2.39287521 |
150 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.37873063 |
151 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.35458769 |
152 | glandular epithelial cell development (GO:0002068) | 2.35031379 |
153 | regulation of glucokinase activity (GO:0033131) | 2.34877645 |
154 | regulation of hexokinase activity (GO:1903299) | 2.34877645 |
155 | chaperone-mediated protein folding (GO:0061077) | 2.31176143 |
156 | valine metabolic process (GO:0006573) | 2.29087962 |
157 | translational initiation (GO:0006413) | 2.29040381 |
158 | oxaloacetate metabolic process (GO:0006107) | 2.28836444 |
159 | glutamine metabolic process (GO:0006541) | 2.28183173 |
160 | proline biosynthetic process (GO:0006561) | 2.26032107 |
161 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.25790651 |
162 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.24457831 |
163 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.23861323 |
164 | pteridine-containing compound metabolic process (GO:0042558) | 2.23241754 |
165 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.23233341 |
166 | maturation of SSU-rRNA (GO:0030490) | 2.23042711 |
167 | RNA stabilization (GO:0043489) | 2.22787621 |
168 | mRNA stabilization (GO:0048255) | 2.22787621 |
169 | cellular response to vitamin D (GO:0071305) | 2.20966319 |
170 | cellular zinc ion homeostasis (GO:0006882) | 2.20097691 |
171 | peptidyl-proline hydroxylation (GO:0019511) | 2.19622928 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.95774601 |
2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.18167967 |
3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.63661659 |
4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.61195689 |
5 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.33369535 |
6 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.97085311 |
7 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.65466803 |
8 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.57683973 |
9 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.54240565 |
10 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.46127159 |
11 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.36023628 |
12 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.35588659 |
13 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.32422328 |
14 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.30316311 |
15 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.28824611 |
16 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.27630130 |
17 | MYC_22102868_ChIP-Seq_BL_Human | 2.20278772 |
18 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.19591238 |
19 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.19344192 |
20 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.18618381 |
21 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.12562655 |
22 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.04071284 |
23 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.02329835 |
24 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.02231023 |
25 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 2.02064936 |
26 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.98276845 |
27 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.88708754 |
28 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.88219200 |
29 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.86431032 |
30 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.86021680 |
31 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.85591516 |
32 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.85406683 |
33 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.84867203 |
34 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.83673216 |
35 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.80810487 |
36 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.78125859 |
37 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.77785802 |
38 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.74025433 |
39 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.73837795 |
40 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.73739785 |
41 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.71925946 |
42 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.70412186 |
43 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.68839763 |
44 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.68279243 |
45 | GATA1_22025678_ChIP-Seq_K562_Human | 1.67919280 |
46 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.67203189 |
47 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64952041 |
48 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.64578114 |
49 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.64130458 |
50 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.62716609 |
51 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.62116810 |
52 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.58521483 |
53 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.58051760 |
54 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.56932586 |
55 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.56626996 |
56 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54591226 |
57 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.53666631 |
58 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.52216549 |
59 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.51265450 |
60 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.50689775 |
61 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.42856837 |
62 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.40861124 |
63 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.35023188 |
64 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.33074252 |
65 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.32336674 |
66 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.29304306 |
67 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.25992809 |
68 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.24267528 |
69 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.23936975 |
70 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.23272607 |
71 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.22334179 |
72 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.21934363 |
73 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.19466332 |
74 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.18546951 |
75 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.18456318 |
76 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17227951 |
77 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.16571138 |
78 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.15460860 |
79 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.13197252 |
80 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.11544829 |
81 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10336110 |
82 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.09686141 |
83 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.08129573 |
84 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.05768313 |
85 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.05530378 |
86 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.04674221 |
87 | EWS_26573619_Chip-Seq_HEK293_Human | 1.04350000 |
88 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.03048562 |
89 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.00808116 |
90 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.00787860 |
91 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.00454250 |
92 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.98208237 |
93 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.97763139 |
94 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.97704385 |
95 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.97452927 |
96 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.97268593 |
97 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.96906823 |
98 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.95897810 |
99 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.95741810 |
100 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.95432948 |
101 | MYB_26560356_Chip-Seq_TH2_Human | 0.94532412 |
102 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.93265048 |
103 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.92379467 |
104 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.91728270 |
105 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.89985006 |
106 | MYB_26560356_Chip-Seq_TH1_Human | 0.89671004 |
107 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.89281414 |
108 | FUS_26573619_Chip-Seq_HEK293_Human | 0.89151889 |
109 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.88067560 |
110 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.87970349 |
111 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.87929082 |
112 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.87539487 |
113 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.85628136 |
114 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.85203354 |
115 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.85189347 |
116 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.83505624 |
117 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.83032747 |
118 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.82786377 |
119 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.82663969 |
120 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.81724456 |
121 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.81377637 |
122 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.79214631 |
123 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.73761631 |
124 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.72870777 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002877_abnormal_melanocyte_morpholog | 4.21711262 |
2 | MP0003693_abnormal_embryo_hatching | 3.09471959 |
3 | MP0010352_gastrointestinal_tract_polyps | 3.03432862 |
4 | MP0006054_spinal_hemorrhage | 2.74110071 |
5 | MP0005220_abnormal_exocrine_pancreas | 2.58138731 |
6 | MP0004957_abnormal_blastocyst_morpholog | 2.32101444 |
7 | MP0009379_abnormal_foot_pigmentation | 2.18355456 |
8 | MP0004264_abnormal_extraembryonic_tissu | 2.09676836 |
9 | MP0003941_abnormal_skin_development | 2.07965915 |
10 | MP0001944_abnormal_pancreas_morphology | 2.05064754 |
11 | MP0002693_abnormal_pancreas_physiology | 2.00333794 |
12 | MP0003806_abnormal_nucleotide_metabolis | 1.92777027 |
13 | MP0003718_maternal_effect | 1.91177869 |
14 | MP0006292_abnormal_olfactory_placode | 1.90403380 |
15 | MP0005365_abnormal_bile_salt | 1.84210037 |
16 | MP0002139_abnormal_hepatobiliary_system | 1.83502703 |
17 | MP0010094_abnormal_chromosome_stability | 1.83196994 |
18 | MP0008057_abnormal_DNA_replication | 1.78643443 |
19 | MP0003077_abnormal_cell_cycle | 1.78469872 |
20 | MP0003786_premature_aging | 1.75804793 |
21 | MP0008007_abnormal_cellular_replicative | 1.74541046 |
22 | MP0003111_abnormal_nucleus_morphology | 1.74343044 |
23 | MP0003123_paternal_imprinting | 1.72908501 |
24 | MP0003315_abnormal_perineum_morphology | 1.67953064 |
25 | MP0003300_gastrointestinal_ulcer | 1.67682711 |
26 | MP0005408_hypopigmentation | 1.63253262 |
27 | MP0004147_increased_porphyrin_level | 1.62889706 |
28 | MP0008877_abnormal_DNA_methylation | 1.58268530 |
29 | MP0002138_abnormal_hepatobiliary_system | 1.54680227 |
30 | MP0002396_abnormal_hematopoietic_system | 1.53936927 |
31 | MP0003195_calcinosis | 1.52180423 |
32 | MP0001293_anophthalmia | 1.51710772 |
33 | MP0005076_abnormal_cell_differentiation | 1.48346332 |
34 | MP0010307_abnormal_tumor_latency | 1.42486551 |
35 | MP0008058_abnormal_DNA_repair | 1.39559548 |
36 | MP0003566_abnormal_cell_adhesion | 1.39493643 |
37 | MP0003705_abnormal_hypodermis_morpholog | 1.38787536 |
38 | MP0003868_abnormal_feces_composition | 1.38544895 |
39 | MP0004808_abnormal_hematopoietic_stem | 1.38197152 |
40 | MP0001730_embryonic_growth_arrest | 1.36939806 |
41 | MP0003890_abnormal_embryonic-extraembry | 1.36500432 |
42 | MP0008438_abnormal_cutaneous_collagen | 1.35602103 |
43 | MP0004197_abnormal_fetal_growth/weight/ | 1.35561351 |
44 | MP0009053_abnormal_anal_canal | 1.34760068 |
45 | MP0003283_abnormal_digestive_organ | 1.34207365 |
46 | MP0009780_abnormal_chondrocyte_physiolo | 1.30361571 |
47 | MP0002234_abnormal_pharynx_morphology | 1.27169150 |
48 | MP0010234_abnormal_vibrissa_follicle | 1.26485027 |
49 | MP0002896_abnormal_bone_mineralization | 1.25491182 |
50 | MP0000490_abnormal_crypts_of | 1.24977735 |
51 | MP0000350_abnormal_cell_proliferation | 1.23742435 |
52 | MP0002909_abnormal_adrenal_gland | 1.23262958 |
53 | MP0001286_abnormal_eye_development | 1.22543496 |
54 | MP0002009_preneoplasia | 1.17241513 |
55 | MP0001188_hyperpigmentation | 1.17061223 |
56 | MP0000013_abnormal_adipose_tissue | 1.13331825 |
57 | MP0003385_abnormal_body_wall | 1.13066551 |
58 | MP0003937_abnormal_limbs/digits/tail_de | 1.12339434 |
59 | MP0001697_abnormal_embryo_size | 1.12302908 |
60 | MP0003252_abnormal_bile_duct | 1.10925404 |
61 | MP0002084_abnormal_developmental_patter | 1.10414047 |
62 | MP0002938_white_spotting | 1.08517442 |
63 | MP0001666_abnormal_nutrient_absorption | 1.07890241 |
64 | MP0004233_abnormal_muscle_weight | 1.07291064 |
65 | MP0009672_abnormal_birth_weight | 1.07232511 |
66 | MP0002086_abnormal_extraembryonic_tissu | 1.06911883 |
67 | MP0010386_abnormal_urinary_bladder | 1.06661769 |
68 | MP0000003_abnormal_adipose_tissue | 1.06513279 |
69 | MP0000678_abnormal_parathyroid_gland | 1.06506967 |
70 | MP0003183_abnormal_peptide_metabolism | 1.05934541 |
71 | MP0005023_abnormal_wound_healing | 1.05918749 |
72 | MP0008875_abnormal_xenobiotic_pharmacok | 1.05453350 |
73 | MP0006035_abnormal_mitochondrial_morpho | 1.05298255 |
74 | MP0002080_prenatal_lethality | 1.04414542 |
75 | MP0003984_embryonic_growth_retardation | 1.03964915 |
76 | MP0001727_abnormal_embryo_implantation | 1.03616321 |
77 | MP0002697_abnormal_eye_size | 1.03522762 |
78 | MP0002088_abnormal_embryonic_growth/wei | 1.03515445 |
79 | MP0005503_abnormal_tendon_morphology | 1.02882200 |
80 | MP0001672_abnormal_embryogenesis/_devel | 1.01896136 |
81 | MP0005380_embryogenesis_phenotype | 1.01896136 |
82 | MP0009697_abnormal_copulation | 1.01699723 |
83 | MP0000858_altered_metastatic_potential | 1.01227735 |
84 | MP0005085_abnormal_gallbladder_physiolo | 1.00378315 |
85 | MP0000598_abnormal_liver_morphology | 1.00077311 |
86 | MP0003121_genomic_imprinting | 0.99326689 |
87 | MP0000358_abnormal_cell_content/ | 0.98981138 |
88 | MP0005501_abnormal_skin_physiology | 0.98453993 |
89 | MP0002078_abnormal_glucose_homeostasis | 0.96825673 |
90 | MP0009703_decreased_birth_body | 0.94149772 |
91 | MP0001881_abnormal_mammary_gland | 0.93178687 |
92 | MP0003122_maternal_imprinting | 0.91971441 |
93 | MP0002019_abnormal_tumor_incidence | 0.91699662 |
94 | MP0002796_impaired_skin_barrier | 0.91324308 |
95 | MP0003186_abnormal_redox_activity | 0.90868450 |
96 | MP0002160_abnormal_reproductive_system | 0.89854144 |
97 | MP0000613_abnormal_salivary_gland | 0.89492077 |
98 | MP0005397_hematopoietic_system_phenotyp | 0.88881602 |
99 | MP0001545_abnormal_hematopoietic_system | 0.88881602 |
100 | MP0008995_early_reproductive_senescence | 0.88875713 |
101 | MP0003436_decreased_susceptibility_to | 0.88666813 |
102 | MP0002233_abnormal_nose_morphology | 0.88160136 |
103 | MP0002210_abnormal_sex_determination | 0.87377993 |
104 | MP0000537_abnormal_urethra_morphology | 0.86475179 |
105 | MP0000516_abnormal_urinary_system | 0.86243885 |
106 | MP0005367_renal/urinary_system_phenotyp | 0.86243885 |
107 | MP0003755_abnormal_palate_morphology | 0.85611709 |
108 | MP0010030_abnormal_orbit_morphology | 0.85447522 |
109 | MP0003950_abnormal_plasma_membrane | 0.85058835 |
110 | MP0002060_abnormal_skin_morphology | 0.84803007 |
111 | MP0002111_abnormal_tail_morphology | 0.84492447 |
112 | MP0008932_abnormal_embryonic_tissue | 0.84457717 |
113 | MP0000609_abnormal_liver_physiology | 0.84373666 |
114 | MP0008789_abnormal_olfactory_epithelium | 0.82620253 |
115 | MP0003119_abnormal_digestive_system | 0.82559293 |
116 | MP0000627_abnormal_mammary_gland | 0.82337853 |
117 | MP0003567_abnormal_fetal_cardiomyocyte | 0.81539587 |
118 | MP0001529_abnormal_vocalization | 0.80647803 |
119 | MP0003795_abnormal_bone_structure | 0.80303296 |
120 | MP0001915_intracranial_hemorrhage | 0.80114965 |
121 | MP0006036_abnormal_mitochondrial_physio | 0.79485312 |
122 | MP0001764_abnormal_homeostasis | 0.79375831 |
123 | MP0003221_abnormal_cardiomyocyte_apopto | 0.78938062 |
124 | MP0002092_abnormal_eye_morphology | 0.78496371 |
125 | MP0000569_abnormal_digit_pigmentation | 0.77108793 |
126 | MP0001243_abnormal_dermal_layer | 0.77061853 |
127 | MP0001145_abnormal_male_reproductive | 0.76597072 |
128 | MP0000762_abnormal_tongue_morphology | 0.75435928 |
129 | MP0002085_abnormal_embryonic_tissue | 0.75043061 |
130 | MP0003787_abnormal_imprinting | 0.74760224 |
131 | MP0005384_cellular_phenotype | 0.74742892 |
132 | MP0000703_abnormal_thymus_morphology | 0.74581565 |
133 | MP0005248_abnormal_Harderian_gland | 0.74174109 |
134 | MP0000428_abnormal_craniofacial_morphol | 0.74139274 |
135 | MP0003943_abnormal_hepatobiliary_system | 0.74091278 |
136 | MP0006072_abnormal_retinal_apoptosis | 0.73062918 |
137 | MP0009333_abnormal_splenocyte_physiolog | 0.72303232 |
138 | MP0003656_abnormal_erythrocyte_physiolo | 0.72160112 |
139 | MP0005621_abnormal_cell_physiology | 0.71937315 |
140 | MP0000313_abnormal_cell_death | 0.71793214 |
141 | MP0003959_abnormal_lean_body | 0.71757457 |
142 | MP0002166_altered_tumor_susceptibility | 0.71291567 |
143 | MP0000371_diluted_coat_color | 0.71235496 |
144 | MP0001929_abnormal_gametogenesis | 0.70564313 |
145 | MP0009643_abnormal_urine_homeostasis | 0.70024183 |
146 | MP0004272_abnormal_basement_membrane | 0.69863618 |
147 | MP0002006_tumorigenesis | 0.69333496 |
148 | MP0000647_abnormal_sebaceous_gland | 0.68058395 |
149 | MP0003935_abnormal_craniofacial_develop | 0.66976376 |
150 | MP0000653_abnormal_sex_gland | 0.66327441 |
151 | MP0004782_abnormal_surfactant_physiolog | 0.66266585 |
152 | MP0003861_abnormal_nervous_system | 0.64803608 |
153 | MP0003936_abnormal_reproductive_system | 0.63648636 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Chromsome breakage (HP:0040012) | 4.32852133 |
2 | Hypoglycemic seizures (HP:0002173) | 3.99188505 |
3 | Hypoglycemic coma (HP:0001325) | 3.87693264 |
4 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.84103556 |
5 | Symptomatic seizures (HP:0011145) | 3.57147514 |
6 | Abnormality of the intrinsic pathway (HP:0010989) | 3.56292951 |
7 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.48199995 |
8 | Reticulocytopenia (HP:0001896) | 3.44844775 |
9 | Thrombocytosis (HP:0001894) | 3.44504530 |
10 | Multiple enchondromatosis (HP:0005701) | 3.41691815 |
11 | Macrocytic anemia (HP:0001972) | 3.23766922 |
12 | Abnormality of the common coagulation pathway (HP:0010990) | 3.09191400 |
13 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.03559899 |
14 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.03559899 |
15 | Abnormality of chromosome stability (HP:0003220) | 2.98860113 |
16 | Cervical subluxation (HP:0003308) | 2.98187863 |
17 | Prominent metopic ridge (HP:0005487) | 2.98115225 |
18 | Increased serum pyruvate (HP:0003542) | 2.94002014 |
19 | Hyperglycemia (HP:0003074) | 2.93005937 |
20 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.92619504 |
21 | Abnormality of methionine metabolism (HP:0010901) | 2.90860270 |
22 | Abnormal lung lobation (HP:0002101) | 2.84208551 |
23 | Acute myeloid leukemia (HP:0004808) | 2.83585115 |
24 | Abnormality of glycolysis (HP:0004366) | 2.82914178 |
25 | Increased nuchal translucency (HP:0010880) | 2.82811272 |
26 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.81659600 |
27 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.79695541 |
28 | Microvesicular hepatic steatosis (HP:0001414) | 2.78216385 |
29 | Embryonal renal neoplasm (HP:0011794) | 2.74092404 |
30 | 11 pairs of ribs (HP:0000878) | 2.71255041 |
31 | Abnormality of the metopic suture (HP:0005556) | 2.68333405 |
32 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.67957498 |
33 | Abnormality of the preputium (HP:0100587) | 2.66845825 |
34 | * Myelodysplasia (HP:0002863) | 2.62666839 |
35 | Degeneration of anterior horn cells (HP:0002398) | 2.61503112 |
36 | Abnormality of the anterior horn cell (HP:0006802) | 2.61503112 |
37 | Meckel diverticulum (HP:0002245) | 2.58372628 |
38 | Increased hepatocellular lipid droplets (HP:0006565) | 2.54645821 |
39 | Abnormal foot bone ossification (HP:0010675) | 2.52277531 |
40 | Beaking of vertebral bodies (HP:0004568) | 2.50510248 |
41 | Duodenal stenosis (HP:0100867) | 2.47150981 |
42 | Small intestinal stenosis (HP:0012848) | 2.47150981 |
43 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.47047760 |
44 | Abnormality of the ileum (HP:0001549) | 2.42580419 |
45 | Missing ribs (HP:0000921) | 2.40524623 |
46 | Limb hypertonia (HP:0002509) | 2.36091925 |
47 | Cortical dysplasia (HP:0002539) | 2.35445179 |
48 | Pallor (HP:0000980) | 2.33134831 |
49 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.30755102 |
50 | Colon cancer (HP:0003003) | 2.29565438 |
51 | Abnormal number of erythroid precursors (HP:0012131) | 2.28848624 |
52 | Proximal placement of thumb (HP:0009623) | 2.28165948 |
53 | Lipid accumulation in hepatocytes (HP:0006561) | 2.25569032 |
54 | Acute necrotizing encephalopathy (HP:0006965) | 2.20097631 |
55 | Metaphyseal cupping (HP:0003021) | 2.17859461 |
56 | Protrusio acetabuli (HP:0003179) | 2.17323626 |
57 | Abnormality of T cell physiology (HP:0011840) | 2.16105599 |
58 | Short middle phalanx of the 5th finger (HP:0004220) | 2.14502134 |
59 | Abnormal biliary tract morphology (HP:0012440) | 2.13455519 |
60 | Late onset (HP:0003584) | 2.12832449 |
61 | Abnormality of the duodenum (HP:0002246) | 2.12531356 |
62 | Severe short stature (HP:0003510) | 2.11100765 |
63 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.10088845 |
64 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.09124818 |
65 | Rhabdomyosarcoma (HP:0002859) | 2.08772086 |
66 | Cutaneous melanoma (HP:0012056) | 2.07910579 |
67 | Thoracolumbar scoliosis (HP:0002944) | 2.07646891 |
68 | Neoplasm of the colon (HP:0100273) | 2.06994196 |
69 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.06700611 |
70 | Acute encephalopathy (HP:0006846) | 2.06624593 |
71 | Osteomalacia (HP:0002749) | 2.06097031 |
72 | Biliary tract neoplasm (HP:0100574) | 2.06049281 |
73 | Abnormality of the labia minora (HP:0012880) | 2.05855983 |
74 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.04030912 |
75 | Vertebral hypoplasia (HP:0008417) | 2.04030912 |
76 | Selective tooth agenesis (HP:0001592) | 2.02303042 |
77 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.01538663 |
78 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.99235770 |
79 | Volvulus (HP:0002580) | 1.98382304 |
80 | Insulin resistance (HP:0000855) | 1.98088124 |
81 | Mucopolysacchariduria (HP:0008155) | 1.95352842 |
82 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.95352842 |
83 | Subacute progressive viral hepatitis (HP:0006572) | 1.94889359 |
84 | Papillary thyroid carcinoma (HP:0002895) | 1.93356635 |
85 | Deep philtrum (HP:0002002) | 1.92712532 |
86 | Mild short stature (HP:0003502) | 1.92538516 |
87 | Enlarged penis (HP:0000040) | 1.92198365 |
88 | Sensory axonal neuropathy (HP:0003390) | 1.92188485 |
89 | Ketoacidosis (HP:0001993) | 1.91436121 |
90 | Increased CSF lactate (HP:0002490) | 1.90645000 |
91 | Reduced antithrombin III activity (HP:0001976) | 1.90358991 |
92 | Type I transferrin isoform profile (HP:0003642) | 1.90061693 |
93 | Premature ovarian failure (HP:0008209) | 1.89688268 |
94 | Acute lymphatic leukemia (HP:0006721) | 1.88597242 |
95 | Triphalangeal thumb (HP:0001199) | 1.88130702 |
96 | Facial cleft (HP:0002006) | 1.87149160 |
97 | Overlapping toe (HP:0001845) | 1.85100346 |
98 | Abnormal number of incisors (HP:0011064) | 1.84524449 |
99 | Abnormal pancreas size (HP:0012094) | 1.83292902 |
100 | Horseshoe kidney (HP:0000085) | 1.82396769 |
101 | Postnatal microcephaly (HP:0005484) | 1.82292600 |
102 | Ankyloglossia (HP:0010296) | 1.81963666 |
103 | Long toe (HP:0010511) | 1.81513312 |
104 | Medulloblastoma (HP:0002885) | 1.80696738 |
105 | Sloping forehead (HP:0000340) | 1.80243883 |
106 | Cerebral edema (HP:0002181) | 1.79356510 |
107 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.78791434 |
108 | Single umbilical artery (HP:0001195) | 1.78791434 |
109 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.78791434 |
110 | Abnormality of the calcaneus (HP:0008364) | 1.78612108 |
111 | Cafe-au-lait spot (HP:0000957) | 1.77946938 |
112 | Secondary amenorrhea (HP:0000869) | 1.77355700 |
113 | Hypoplastic labia majora (HP:0000059) | 1.76483707 |
114 | Intrahepatic cholestasis (HP:0001406) | 1.76202005 |
115 | Abnormality of the fingertips (HP:0001211) | 1.76162068 |
116 | Macroorchidism (HP:0000053) | 1.74904784 |
117 | Ectopic kidney (HP:0000086) | 1.74336010 |
118 | Long foot (HP:0001833) | 1.74119967 |
119 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.73985989 |
120 | Hypoplasia of the pons (HP:0012110) | 1.73818261 |
121 | Hypobetalipoproteinemia (HP:0003563) | 1.73656413 |
122 | Deviation of the thumb (HP:0009603) | 1.73102322 |
123 | Respiratory difficulties (HP:0002880) | 1.72166279 |
124 | Increased serum lactate (HP:0002151) | 1.71862351 |
125 | Glossoptosis (HP:0000162) | 1.71367394 |
126 | Generalized aminoaciduria (HP:0002909) | 1.71341261 |
127 | Atresia of the external auditory canal (HP:0000413) | 1.70533517 |
128 | Stenosis of the external auditory canal (HP:0000402) | 1.70117798 |
129 | Ependymoma (HP:0002888) | 1.69852250 |
130 | Progressive macrocephaly (HP:0004481) | 1.69799167 |
131 | Optic nerve coloboma (HP:0000588) | 1.69608435 |
132 | Choanal atresia (HP:0000453) | 1.68859042 |
133 | Abnormality of the umbilical cord (HP:0010881) | 1.67931163 |
134 | Abnormality of homocysteine metabolism (HP:0010919) | 1.67776657 |
135 | Homocystinuria (HP:0002156) | 1.67776657 |
136 | Diastasis recti (HP:0001540) | 1.66532932 |
137 | Microglossia (HP:0000171) | 1.66017242 |
138 | Slender long bone (HP:0003100) | 1.65954676 |
139 | Conjugated hyperbilirubinemia (HP:0002908) | 1.64724869 |
140 | Capillary hemangiomas (HP:0005306) | 1.64458142 |
141 | Epiphyseal dysplasia (HP:0002656) | 1.64376983 |
142 | Intestinal polyposis (HP:0200008) | 1.64183840 |
143 | Hypochromic microcytic anemia (HP:0004840) | 1.63653966 |
144 | Hepatocellular carcinoma (HP:0001402) | 1.63320722 |
145 | Long clavicles (HP:0000890) | 1.63192107 |
146 | Nonimmune hydrops fetalis (HP:0001790) | 1.63106680 |
147 | Abnormality of the acetabulum (HP:0003170) | 1.63098768 |
148 | Cystic hygroma (HP:0000476) | 1.62937755 |
149 | Hypoplasia of the odontoid process (HP:0003311) | 1.61943588 |
150 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.61438175 |
151 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.61438175 |
152 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.61438175 |
153 | Periodontitis (HP:0000704) | 1.61112011 |
154 | Abnormality of the carotid arteries (HP:0005344) | 1.59426962 |
155 | Abnormal tarsal ossification (HP:0008369) | 1.58985020 |
156 | Birth length less than 3rd percentile (HP:0003561) | 1.58854288 |
157 | Spondylolisthesis (HP:0003302) | 1.58753000 |
158 | Broad palm (HP:0001169) | 1.58514679 |
159 | Platyspondyly (HP:0000926) | 1.57938590 |
160 | Curly hair (HP:0002212) | 1.57288544 |
161 | Oral leukoplakia (HP:0002745) | 1.57100923 |
162 | Trismus (HP:0000211) | 1.56566757 |
163 | Coxa valga (HP:0002673) | 1.56466524 |
164 | Hypoplastic pelvis (HP:0008839) | 1.56222410 |
165 | Megaloblastic anemia (HP:0001889) | 1.55918039 |
166 | Neoplasm of the liver (HP:0002896) | 1.55294353 |
167 | Intestinal polyp (HP:0005266) | 1.55135731 |
168 | Freckling (HP:0001480) | 1.54601198 |
169 | Ovarian neoplasm (HP:0100615) | 1.54575072 |
170 | Progressive muscle weakness (HP:0003323) | 1.54474039 |
171 | Neuroblastic tumors (HP:0004376) | 1.54297489 |
172 | Peripheral primitive neuroectodermal neoplasm (HP:0030067) | 1.54297489 |
173 | Primitive neuroectodermal tumor (HP:0030065) | 1.54297489 |
174 | Increased mean platelet volume (HP:0011877) | 1.54076150 |
175 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.53821544 |
176 | Unilateral renal agenesis (HP:0000122) | 1.52662408 |
177 | Exostoses (HP:0100777) | 1.52306807 |
178 | Abnormality of the labia majora (HP:0012881) | 1.52154590 |
179 | Long palpebral fissure (HP:0000637) | 1.51286005 |
180 | Abnormal cartilage morphology (HP:0002763) | 1.51284905 |
181 | Abnormal platelet volume (HP:0011876) | 1.50958470 |
182 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.50474832 |
183 | Hypochromic anemia (HP:0001931) | 1.49968831 |
184 | Thyroid carcinoma (HP:0002890) | 1.48653653 |
185 | Spastic diplegia (HP:0001264) | 1.48037606 |
186 | Back pain (HP:0003418) | 1.47282340 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PASK | 4.47518036 |
2 | PBK | 2.93852701 |
3 | SCYL2 | 2.82763434 |
4 | EEF2K | 2.59828784 |
5 | FRK | 2.56054488 |
6 | TAOK3 | 2.53926117 |
7 | CDC7 | 2.49921602 |
8 | STK16 | 2.46421136 |
9 | INSRR | 2.45624823 |
10 | EIF2AK3 | 2.27222491 |
11 | ERN1 | 2.22229082 |
12 | BRSK2 | 2.16633847 |
13 | TRIB3 | 2.10688236 |
14 | PKN2 | 2.10467163 |
15 | FLT3 | 2.06916819 |
16 | TSSK6 | 1.98468813 |
17 | TGFBR1 | 1.87339625 |
18 | MST4 | 1.80346004 |
19 | TRIM28 | 1.76862748 |
20 | VRK2 | 1.69214144 |
21 | PNCK | 1.66522806 |
22 | EIF2AK1 | 1.64210246 |
23 | RPS6KA4 | 1.60091329 |
24 | NEK9 | 1.44235343 |
25 | ERBB3 | 1.44188061 |
26 | CHEK2 | 1.43530042 |
27 | SRPK1 | 1.41804465 |
28 | ACVR1B | 1.38578076 |
29 | AKT3 | 1.37154438 |
30 | PLK3 | 1.34907494 |
31 | TESK1 | 1.34785109 |
32 | BRD4 | 1.34473154 |
33 | MAP3K10 | 1.33787232 |
34 | LATS1 | 1.32508963 |
35 | CDK12 | 1.28311867 |
36 | HIPK2 | 1.27974832 |
37 | LRRK2 | 1.25420767 |
38 | TAF1 | 1.25038424 |
39 | PTK6 | 1.24726087 |
40 | CLK1 | 1.24599403 |
41 | RPS6KB2 | 1.22691896 |
42 | TNIK | 1.20972462 |
43 | EIF2AK2 | 1.19752655 |
44 | BCKDK | 1.17394251 |
45 | ATR | 1.16944095 |
46 | JAK3 | 1.16465769 |
47 | MAP3K12 | 1.13604513 |
48 | WEE1 | 1.12035882 |
49 | MAP3K2 | 1.10199018 |
50 | VRK1 | 1.08858809 |
51 | ZAK | 1.07449811 |
52 | CDK6 | 1.06290994 |
53 | BCR | 1.05214977 |
54 | NME2 | 1.01392602 |
55 | PIK3CG | 0.96986779 |
56 | PIM2 | 0.95736903 |
57 | EPHA2 | 0.94917353 |
58 | MKNK1 | 0.94399160 |
59 | RPS6KB1 | 0.93904815 |
60 | TEC | 0.93490137 |
61 | BTK | 0.91876255 |
62 | IRAK3 | 0.88232035 |
63 | PRKD3 | 0.82605653 |
64 | MTOR | 0.81872993 |
65 | AURKB | 0.81867743 |
66 | PAK4 | 0.80135915 |
67 | SIK3 | 0.80025361 |
68 | SIK1 | 0.79457360 |
69 | ATM | 0.79115520 |
70 | ALK | 0.78373244 |
71 | NEK2 | 0.77803677 |
72 | PDGFRA | 0.76135814 |
73 | CDK7 | 0.75920926 |
74 | RPS6KA2 | 0.75904687 |
75 | CHEK1 | 0.75898626 |
76 | ZAP70 | 0.75888627 |
77 | NME1 | 0.74250708 |
78 | PDK2 | 0.74041395 |
79 | MAP3K8 | 0.72245301 |
80 | PIM1 | 0.72215878 |
81 | EPHA3 | 0.71461803 |
82 | CSNK1E | 0.71123050 |
83 | MAP3K3 | 0.70860299 |
84 | MST1R | 0.68310119 |
85 | NEK1 | 0.67893842 |
86 | STK4 | 0.67855166 |
87 | PLK2 | 0.67195505 |
88 | CDK9 | 0.66998117 |
89 | MAP2K3 | 0.66968951 |
90 | PLK4 | 0.66792799 |
91 | CDK1 | 0.66370918 |
92 | CDK4 | 0.66223516 |
93 | ERBB4 | 0.66180093 |
94 | STK10 | 0.65558115 |
95 | FER | 0.62604118 |
96 | TTK | 0.61830422 |
97 | CSNK2A1 | 0.60207094 |
98 | STK3 | 0.60003777 |
99 | DYRK3 | 0.59148667 |
100 | FGFR1 | 0.58074826 |
101 | MET | 0.57946635 |
102 | AURKA | 0.57919927 |
103 | TRPM7 | 0.57684873 |
104 | BRAF | 0.57572673 |
105 | PLK1 | 0.56629033 |
106 | CSNK2A2 | 0.56529986 |
107 | FGFR3 | 0.55644909 |
108 | CDK2 | 0.54467193 |
109 | ITK | 0.53159970 |
110 | PTK2 | 0.53122390 |
111 | CHUK | 0.52813790 |
112 | IRAK4 | 0.52269644 |
113 | BRSK1 | 0.52261272 |
114 | BMPR2 | 0.52128422 |
115 | BUB1 | 0.48515624 |
116 | LATS2 | 0.48225310 |
117 | PAK2 | 0.47897075 |
118 | TESK2 | 0.47116408 |
119 | CCNB1 | 0.46658774 |
120 | JAK2 | 0.46127447 |
121 | MAP3K5 | 0.45442452 |
122 | FGFR4 | 0.45290698 |
123 | MAP4K1 | 0.45180386 |
124 | ILK | 0.45130782 |
125 | MKNK2 | 0.44845581 |
126 | CDK8 | 0.42330984 |
127 | PRKCI | 0.42217653 |
128 | PRKDC | 0.41504327 |
129 | CDK19 | 0.38841071 |
130 | CDK3 | 0.38047902 |
131 | STK38L | 0.36861860 |
132 | AKT2 | 0.36488520 |
133 | MAPK14 | 0.36344981 |
134 | MINK1 | 0.35759612 |
135 | NUAK1 | 0.35522930 |
136 | DYRK1B | 0.34738521 |
137 | RPS6KC1 | 0.34591928 |
138 | KSR1 | 0.26815565 |
139 | CDK18 | 0.25485823 |
140 | CDK11A | 0.25358280 |
141 | CDK14 | 0.24130124 |
142 | BMPR1B | 0.23855364 |
143 | PAK1 | 0.23410631 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.63129605 |
2 | * Protein export_Homo sapiens_hsa03060 | 4.23275114 |
3 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.62551040 |
4 | One carbon pool by folate_Homo sapiens_hsa00670 | 3.31854778 |
5 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.88013419 |
6 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.64010207 |
7 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.25991072 |
8 | RNA transport_Homo sapiens_hsa03013 | 2.19206038 |
9 | DNA replication_Homo sapiens_hsa03030 | 2.17672793 |
10 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.98660989 |
11 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.90704465 |
12 | Mismatch repair_Homo sapiens_hsa03430 | 1.88739973 |
13 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.85707050 |
14 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.76707228 |
15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.68530535 |
16 | Spliceosome_Homo sapiens_hsa03040 | 1.63708122 |
17 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.56115826 |
18 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.51472545 |
19 | Cell cycle_Homo sapiens_hsa04110 | 1.51378729 |
20 | Thyroid cancer_Homo sapiens_hsa05216 | 1.45335242 |
21 | Ribosome_Homo sapiens_hsa03010 | 1.41457039 |
22 | Base excision repair_Homo sapiens_hsa03410 | 1.40833162 |
23 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.38169091 |
24 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.27632717 |
25 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.27222431 |
26 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.26720584 |
27 | Parkinsons disease_Homo sapiens_hsa05012 | 1.26013233 |
28 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.18563023 |
29 | RNA degradation_Homo sapiens_hsa03018 | 1.18172783 |
30 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.17310194 |
31 | Proteasome_Homo sapiens_hsa03050 | 1.17132714 |
32 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.16543331 |
33 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.15056497 |
34 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.13366791 |
35 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.12858077 |
36 | Huntingtons disease_Homo sapiens_hsa05016 | 1.06853362 |
37 | Carbon metabolism_Homo sapiens_hsa01200 | 1.06288695 |
38 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.05644335 |
39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.05536741 |
40 | Galactose metabolism_Homo sapiens_hsa00052 | 1.05492763 |
41 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.04406823 |
42 | Lysine degradation_Homo sapiens_hsa00310 | 1.00033626 |
43 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.98763803 |
44 | Legionellosis_Homo sapiens_hsa05134 | 0.96723978 |
45 | Bladder cancer_Homo sapiens_hsa05219 | 0.94425773 |
46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.94064804 |
47 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92316449 |
48 | Homologous recombination_Homo sapiens_hsa03440 | 0.90855904 |
49 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.89346285 |
50 | RNA polymerase_Homo sapiens_hsa03020 | 0.88689592 |
51 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.88667121 |
52 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.85310676 |
53 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.81442255 |
54 | Prostate cancer_Homo sapiens_hsa05215 | 0.80992478 |
55 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.79030519 |
56 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.77669715 |
57 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.73987741 |
58 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.73092489 |
59 | Other glycan degradation_Homo sapiens_hsa00511 | 0.72844847 |
60 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.71596244 |
61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70397781 |
62 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.70019458 |
63 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.69952927 |
64 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.69839611 |
65 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.69075446 |
66 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.66642763 |
67 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.64988817 |
68 | Insulin resistance_Homo sapiens_hsa04931 | 0.64241513 |
69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.64141201 |
70 | Alzheimers disease_Homo sapiens_hsa05010 | 0.61929882 |
71 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.60775980 |
72 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.60531919 |
73 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59208114 |
74 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.58972992 |
75 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.58671242 |
76 | Hepatitis B_Homo sapiens_hsa05161 | 0.55951761 |
77 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.55417850 |
78 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.54230970 |
79 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.54073806 |
80 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.53910064 |
81 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.53741339 |
82 | Basal transcription factors_Homo sapiens_hsa03022 | 0.53304328 |
83 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.53225259 |
84 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.53053935 |
85 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.52067067 |
86 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.51129064 |
87 | Endometrial cancer_Homo sapiens_hsa05213 | 0.50832420 |
88 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50583285 |
89 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.50312385 |
90 | Adherens junction_Homo sapiens_hsa04520 | 0.50097876 |
91 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.49211229 |
92 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.48255595 |
93 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.47001167 |
94 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.46663448 |
95 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.45702491 |
96 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.45469863 |
97 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.45462073 |
98 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.44928637 |
99 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.44468731 |
100 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41312827 |
101 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.40807532 |
102 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.40655515 |
103 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.40439492 |
104 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.40426438 |
105 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.39939087 |
106 | Measles_Homo sapiens_hsa05162 | 0.39739782 |
107 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.39359927 |
108 | Colorectal cancer_Homo sapiens_hsa05210 | 0.36605683 |
109 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.36087783 |
110 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.36009074 |
111 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.35059691 |
112 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34982804 |
113 | Purine metabolism_Homo sapiens_hsa00230 | 0.32865724 |
114 | Apoptosis_Homo sapiens_hsa04210 | 0.31590894 |
115 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.31571674 |
116 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.31280595 |
117 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.31241846 |
118 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.30751063 |
119 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.29748059 |
120 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.28941910 |
121 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.28555788 |
122 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.28123553 |
123 | Shigellosis_Homo sapiens_hsa05131 | 0.21988306 |
124 | Melanoma_Homo sapiens_hsa05218 | 0.21848273 |
125 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.21386740 |
126 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.19111957 |
127 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.18425186 |
128 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.15286425 |
129 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.14592069 |
130 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.13469477 |
131 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.13185752 |
132 | Pathways in cancer_Homo sapiens_hsa05200 | 0.11798783 |
133 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.07292585 |
134 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.05718287 |
135 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.01977255 |
136 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.01676879 |